Turn Therapeutics Inc. - COM (TTRX)

CUSIP: 90021W105

Q3 2026 13F Holders as of 30 Sep 2026

Share change
+925,451
SEC-reported price per share
$14.39
Indexed holders
29
Value change
+$13,453,522
Number of buys
18
Number of sells
3

Security key

90021W105

Report period

Q3 2026

Indexed institutions

29

Top holders

10

Ownership snapshot

Top reported holders of TTRX - Turn Therapeutics Inc. - COM (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
BEB Holdings, LLC
Disclosed value leader
BEB Holdings, LLC
Comparable rows
0/15
Latest evidence
30 Jun 2026
3/4/5 13F Highest disclosed value: $49,332,032 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

BEB Holdings, LLC has the largest disclosed position value at $49.33M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BEB Holdings, LLC's linked filing trail.
Disclosed position value Top 5
BEB Holdings, LLC $49.33M
Bradley Evan Burnam $49.33M
SteelPeak Wealth, LLC $1.82M
IEQ CAPITAL, LLC $1.66M
Arthur F. Golden $1.42M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
BEB Holdings, LLC
3/4/5
10%+ Owner
—
mixed-class rows
$49,332,032
15,576,260 shares
mixed-class rows
— 28 May 2026
Bradley Evan Burnam
3/4/5
Chief Executive Officer, Director, 10%+ Owner
—
mixed-class rows
$49,332,032
15,576,260 shares
mixed-class rows
— 28 May 2026
SteelPeak Wealth, LLC
13F
Company
13F
—
denominator unverified
$1,821,029
249,456 shares
— 30 Jun 2026
IEQ CAPITAL, LLC
13F
Company
13F
—
denominator unverified
$1,659,991
227,396 shares
— 30 Jun 2026
Arthur F. Golden
3/4/5
Director
—
mixed-class rows
$1,420,771
450,186 shares
mixed-class rows
+$33,946 04 Jun 2026
DDFG, Inc
13F
Company
13F
—
denominator unverified
$787,154
107,829 shares
— 30 Jun 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
29
Shares
1,692,853
Indexed holders
29
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q3 2026 vs Q2 2026 Across Filers

Q2 2026 indexed holders
29
Q3 2026 indexed holders
29
Indexed holder difference
0
Investor Q2 2026 Shares Q3 2026 Shares Share Diff Share Chg % Q2 2026 value Q3 2026 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .